These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 15800797
21. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V, Hutchins B. Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
22. Cyclooxygenase-2. A key regulator of bladder prostaglandin formation. Park JM, Schnermann JB, Briggs JP. Adv Exp Med Biol; 1999 Feb; 462():171-81. PubMed ID: 10599422 [No Abstract] [Full Text] [Related]
23. [Progress in the therapy of rheumatism]. Heinzl S. Med Monatsschr Pharm; 1999 Aug; 22(8):225. PubMed ID: 10481432 [No Abstract] [Full Text] [Related]
24. [Selective inhibitors of cyclooxygenase-2: new perspectives of human diseases management]. Nasonov EL, Tsvetkova ES, Tov NL. Ter Arkh; 1998 Aug; 70(5):8-14. PubMed ID: 9644734 [No Abstract] [Full Text] [Related]
27. [Safe use of anti-inflammatory analgesics]. Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society. Duodecim; 2003 Jan; 119(22):2167-71. PubMed ID: 14702803 [No Abstract] [Full Text] [Related]
28. [New anti-inflammatory analgetics--are they needed?]. Paakkari I. Duodecim; 1999 Jan; 115(20):2217-24. PubMed ID: 11973925 [No Abstract] [Full Text] [Related]
29. My most difficult choice. Saporito B. Time; 2005 May 23; 165(21):64-5. PubMed ID: 15926776 [No Abstract] [Full Text] [Related]
30. Treatment of rheumatoid arthritis--we're getting closer. Kushner I, Ballou SP. J Rheumatol; 1999 Nov 23; 26(11):2291-3. PubMed ID: 10555878 [No Abstract] [Full Text] [Related]
31. Report of the 11th Annual Meeting of ISAP (International Society of Anaesthetic Pharmacology--formerly SIVA). Sear JW, Bovill JG. Anesth Analg; 2003 May 23; 96(5):1522-5. PubMed ID: 12707161 [No Abstract] [Full Text] [Related]
32. [Topical pharmacology. COX-2 inhibitors]. Heinzl S. Med Monatsschr Pharm; 1999 Oct 23; 22(10):298-304. PubMed ID: 10540801 [No Abstract] [Full Text] [Related]
33. COX-2 and COX-2 enzyme inhibition. Conti P. Int J Immunopathol Pharmacol; 2003 Oct 23; 16(2 Suppl):I-II. PubMed ID: 14552697 [No Abstract] [Full Text] [Related]
34. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs. Housholder GT, Chan JT. J Gt Houst Dent Soc; 1997 Mar 23; 68(8):13-6. PubMed ID: 9594801 [No Abstract] [Full Text] [Related]
35. Cutting-edge pharmacotherapeutics. Mege J. Pa Med; 1998 Dec 23; 101(12):17, 22. PubMed ID: 9883028 [No Abstract] [Full Text] [Related]
36. Herbal medicine, cancer prevention and cyclooxygenase 2 inhibition. Izzo AA, Capasso F. Trends Pharmacol Sci; 2003 May 23; 24(5):218-9. PubMed ID: 12767718 [No Abstract] [Full Text] [Related]
37. Clinical experience with cyclooxygenase-2 inhibitors. van Ryn J, Pairet M. Inflamm Res; 1999 May 23; 48(5):247-54. PubMed ID: 10391112 [Abstract] [Full Text] [Related]
38. Getting a grip on pain. A new drug may revolutionize arthritis care. Cowley G. Newsweek; 1998 Dec 14; 132(24):66. PubMed ID: 10338868 [No Abstract] [Full Text] [Related]
39. Challenge in the treatment of estrogen-receptor-negative ductal carcinoma in situ. Altundag K. J Clin Oncol; 2005 Jul 01; 23(19):4469-70. PubMed ID: 15994163 [No Abstract] [Full Text] [Related]
40. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers]. Eschwege P. Bull Cancer; 2004 May 01; 91 Suppl 2():S113-6. PubMed ID: 15899635 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]